ResMed Inc. (RMD)
NYSE: RMD
· Real-Time Price · USD
273.77
4.56 (1.69%)
At close: Sep 04, 2025, 3:59 PM
277.28
1.28%
After-hours: Sep 04, 2025, 05:31 PM EDT
1.69% (1D)
| Bid | 270 |
| Market Cap | 40.08B |
| Revenue (ttm) | 5.15B |
| Net Income (ttm) | 1.4B |
| EPS (ttm) | 9.5 |
| PE Ratio (ttm) | 28.82 |
| Forward PE | 24.76 |
| Analyst | Buy |
| Ask | 278.49 |
| Volume | 787,396 |
| Avg. Volume (20D) | 1,055,475.3 |
| Open | 270.30 |
| Previous Close | 269.21 |
| Day's Range | 267.57 - 274.24 |
| 52-Week Range | 199.92 - 293.81 |
| Beta | 0.77 |
Analyst Forecast
According to 0 analyst ratings, the average rating for RMD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
ResMed Inc. is scheduled to release its earnings on
Oct 23, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+2.67%
ResMed shares are trading higher after the company...
Unlock content with
Pro Subscription
4 months ago
+10.14%
ResMed shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results. Also, Keybanc maintained an Overweight rating on the stock and raised its price target from $269 to $274.
